NURECA
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Nureca Ltd In-Principally Approves Merger Of Nureca Technologies With Co
May 7 (Reuters) - Nureca Ltd NURE.NS:
IN-PRINCIPALLY APPROVES MERGER OF NURECA TECHNOLOGIES WITH CO
Source text: ID:nNSE3dg7jF
Further company coverage: NURE.NS
(([email protected];;))
May 7 (Reuters) - Nureca Ltd NURE.NS:
IN-PRINCIPALLY APPROVES MERGER OF NURECA TECHNOLOGIES WITH CO
Source text: ID:nNSE3dg7jF
Further company coverage: NURE.NS
(([email protected];;))
India's Nureca jumps as unit gets registration approval from USFDA
** Shares of Nureca NURE.NS gain as much as 5% to 225.1 rupees, last up 4.3%
** Healthcare and wellness product maker's unit completed registration with the United States Food and Drug Administration (USFDA)
** Medical devices from the unit's plant in Punjab state including beds and stethoscope now listed with USFDA for manufacturing and exports
** Stock down 24% so far this year
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364))
** Shares of Nureca NURE.NS gain as much as 5% to 225.1 rupees, last up 4.3%
** Healthcare and wellness product maker's unit completed registration with the United States Food and Drug Administration (USFDA)
** Medical devices from the unit's plant in Punjab state including beds and stethoscope now listed with USFDA for manufacturing and exports
** Stock down 24% so far this year
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364))
India's Nureca rises after favourable injunction from court
** Healthcare and wellness products maker Nureca NURE.NS rises 9.5% to 333.60 rupees
** Co gets favourable injunction from commercial court against Threpsi Solutions, ARC International and Tech-Connect Retail
** Injunction restrains passing, selling marketing products using NURE's registered trademark "SUPERVOLT" or any deceptively similar mark
** Around 151,005 shares traded, ~4x the 30-day avg
** NURE fell ~34% in 2024
(Reporting by Vijay Malkar)
(([email protected];))
** Healthcare and wellness products maker Nureca NURE.NS rises 9.5% to 333.60 rupees
** Co gets favourable injunction from commercial court against Threpsi Solutions, ARC International and Tech-Connect Retail
** Injunction restrains passing, selling marketing products using NURE's registered trademark "SUPERVOLT" or any deceptively similar mark
** Around 151,005 shares traded, ~4x the 30-day avg
** NURE fell ~34% in 2024
(Reporting by Vijay Malkar)
(([email protected];))
Nureca Acquires Shares Of Yes Bank For 9.7 Million Rupees
Dec 6 (Reuters) - Nureca Ltd NURE.NS:
NURECA LTD - ACQUIRED SHARES OF YES BANK FOR 9.7 MILLION RUPEES
Source text: ID:nBSE2mqXS6
Further company coverage: NURE.NS
(([email protected];))
Dec 6 (Reuters) - Nureca Ltd NURE.NS:
NURECA LTD - ACQUIRED SHARES OF YES BANK FOR 9.7 MILLION RUPEES
Source text: ID:nBSE2mqXS6
Further company coverage: NURE.NS
(([email protected];))
Nureca Acquires Shares Of IndusInd Bank Worth 15 Mln Rupees
Dec 4 (Reuters) - Nureca Ltd NURE.NS:
ACQUIRED SHARES OF INDUSIND BANK WORTH 15 MILLION RUPEES
Source text: ID:nBSE5BC2L4
Further company coverage: INBK.NS
(([email protected];;))
Dec 4 (Reuters) - Nureca Ltd NURE.NS:
ACQUIRED SHARES OF INDUSIND BANK WORTH 15 MILLION RUPEES
Source text: ID:nBSE5BC2L4
Further company coverage: INBK.NS
(([email protected];;))
India's Nureca gains on distribution deal with Zepto
** Shares of healthcare products maker Nureca NURE.NS jump as much as 5.3% to 285.45 rupees
** Co on Saturday entered into an agreement with quick commerce firm Zepto to get NURE's products on Zepto's platform
** Terms of the deal were not disclosed, citing confidentiality
** Stock on track to log biggest one-day gain in around two weeks if trends hold
** NURE last up ~2%, trimming YTD losses to 35%
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
** Shares of healthcare products maker Nureca NURE.NS jump as much as 5.3% to 285.45 rupees
** Co on Saturday entered into an agreement with quick commerce firm Zepto to get NURE's products on Zepto's platform
** Terms of the deal were not disclosed, citing confidentiality
** Stock on track to log biggest one-day gain in around two weeks if trends hold
** NURE last up ~2%, trimming YTD losses to 35%
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
Nureca Says Due To Additional Orders, Sales May Exceed Materiality Threshold In Current Quarter
Sept 17 (Reuters) - Nureca Ltd NURE.NS:
NURECA LTD - ENTERED INTO A DISTRIBUTION AGREEMENT
NURECA - DUE TO ADDITIONAL ORDERS, SALES MAY EXCEED MATERIALITY THRESHOLD IN CURRENT QUARTER
Source text for Eikon: ID:nBSE1ngLKH
Further company coverage: NURE.NS
(([email protected];))
Sept 17 (Reuters) - Nureca Ltd NURE.NS:
NURECA LTD - ENTERED INTO A DISTRIBUTION AGREEMENT
NURECA - DUE TO ADDITIONAL ORDERS, SALES MAY EXCEED MATERIALITY THRESHOLD IN CURRENT QUARTER
Source text for Eikon: ID:nBSE1ngLKH
Further company coverage: NURE.NS
(([email protected];))
Nureca Ltd Approves Appointment Of Naresh Gupta As Chief Financial Officer
Nov 20 (Reuters) - Nureca Ltd NURE.NS:
NURECA LTD - APPROVED APPOINTMENT OF NARESH GUPTA AS CHIEF FINANCIAL OFFICER
Source text for Eikon: ID:nNSE6vZksR
Further company coverage: NURE.NS
(([email protected];))
Nov 20 (Reuters) - Nureca Ltd NURE.NS:
NURECA LTD - APPROVED APPOINTMENT OF NARESH GUPTA AS CHIEF FINANCIAL OFFICER
Source text for Eikon: ID:nNSE6vZksR
Further company coverage: NURE.NS
(([email protected];))
Nureca CFO Nishant Garg Resigns
Sept 7 (Reuters) - Nureca Ltd NURE.NS:
NISHANT GARG RESIGNS AS CFO
Source text for Eikon: [ID:]
Further company coverage: NURE.NS
(([email protected];;))
Sept 7 (Reuters) - Nureca Ltd NURE.NS:
NISHANT GARG RESIGNS AS CFO
Source text for Eikon: [ID:]
Further company coverage: NURE.NS
(([email protected];;))
Events:
Dividend
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Nureca Ltd. do?
Nureca Limited is a B2C company offering quality home healthcare and wellness products with innovative designs, sold through online channels and its own website drtrust.in, targeting a wider customer base with a diverse product portfolio.
Who are the competitors of Nureca Ltd.?
Nureca Ltd. major competitors are QMS Medi Allied Ser., 3B Blackbio Dx, TTK Healthcare, Poly Medicure, Rajnish Wellness, Sastasundar Ventures, Max India. Market Cap of Nureca Ltd. is ₹275 Crs. While the median market cap of its peers are ₹991 Crs.
Is Nureca Ltd. financially stable compared to its competitors?
Nureca Ltd. seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Nureca Ltd. pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Nureca Ltd. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Nureca Ltd. allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Nureca Ltd. balance sheet?
Balance sheet of Nureca Ltd. is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Nureca Ltd. improving?
Yes, profit is increasing. The profit of Nureca Ltd. is ₹0.85 Crs for Mar 2025, -₹1.79 Crs for Mar 2024 and -₹8.25 Crs for Mar 2023
Is the debt of Nureca Ltd. increasing or decreasing?
The net debt of Nureca Ltd. is decreasing. Latest net debt of Nureca Ltd. is -₹90.13 Crs as of Mar-25. This is less than Mar-24 when it was -₹90.12 Crs.
Is Nureca Ltd. stock expensive?
Nureca Ltd. is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Nureca Ltd. is 325, while 3 year average PE is 108. Also latest EV/EBITDA of Nureca Ltd. is 0.0 while 3yr average is 27.29.
Has the share price of Nureca Ltd. grown faster than its competition?
Nureca Ltd. has given lower returns compared to its competitors. Nureca Ltd. has grown at ~-13.54% over the last 2yrs while peers have grown at a median rate of 0.52%
Is the promoter bullish about Nureca Ltd.?
Promoters seem to be bullish about the company. Latest quarter promoter holding is 64.3% and last quarter promoter holding is 64.06%.
Are mutual funds buying/selling Nureca Ltd.?
There is Insufficient data to gauge this.